Press Release Coincheck Group Signs Agreement to Acquire 3iQ, a Global Pioneer in Digital Asset Investment Solutions 8 January 2026
Press Release Candid Therapeutics Plans to Initiate Multiple Phase 2 Studies Following Promising Clinical Data of T-cell Engagers in Autoimmune Diseases 8 January 2026
Press Release TransactionTree Appoints Kevin Saum as Chief Executive Officer to Lead Next Phase of Growth 8 January 2026
Press Release VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS 8 January 2026
Press Release Parabilis Medicines Announces Oversubscribed $305 Million Financing to Support Ongoing FOG-001 (zolucatetide) Clinical Development Across a Broad Range of Tumors and Advance Pioneering Pipeline and Helicon Platform 8 January 2026
Press Release Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit 8 January 2026
